Abstract. The traveling salesman problem (TSP) belongs to the most basic, most important, and most investigated problems in combinatorial optimization. Although it is an N P-hard problem, many of its special cases can be solved efficiently in polynomial time. We survey these special cases with emphasis on the results that have been obtained during the decade [1985][1986][1987][1988][1989][1990][1991][1992][1993][1994][1995]
In the maximum constraint satisfaction problem (Max CSP), one is given a finite collection of (possibly weighted) constraints on overlapping sets of variables, and the goal is to assign values from a given finite domain to the variables so as to maximize the number (or the total weight, for the weighted case) of satisfied constraints. This problem is NP-hard in general, and, therefore, it is natural to study how restricting the allowed types of constraints affects the approximability of the problem. In this paper, we show that any Max CSP problem with a finite set of allowed constraint types, which includes all fixed-value constraints (i.e., constraints of the form x = a), is either solvable exactly in polynomial time or else is APX-complete, even if the number of occurrences of variables in instances is bounded. Moreover, we present a simple description of all polynomial-time solvable cases of our problem. This description relies on the well-known algebraic combinatorial property of supermodularity.
We solve the special case of the Euclidean Traveling Salesman Problem where n m cities lie on the boundary of the convex hull of all n cities, and the other m cities lie on a line segment inside this convex hull by an algorithm which needs Omn time and On space.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.